Nuveen Asset Management, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$7,145,969
-34.2%
265,946
-12.7%
0.00%
-25.0%
Q2 2023$10,865,138
+154212.4%
304,687
+9.9%
0.00%
+33.3%
Q1 2023$7,041
-55.6%
277,226
-29.2%
0.00%
-50.0%
Q4 2022$15,872
-99.9%
391,327
-17.9%
0.01%0.0%
Q3 2022$15,744,000
-36.1%
476,375
-32.0%
0.01%
-40.0%
Q2 2022$24,656,000
-14.6%
700,276
+10.1%
0.01%
+11.1%
Q1 2022$28,872,000
-15.3%
635,934
+23.8%
0.01%
-10.0%
Q4 2021$34,069,000
+12.0%
513,850
+5.5%
0.01%
+11.1%
Q3 2021$30,413,000
-28.1%
487,163
-4.6%
0.01%
-30.8%
Q2 2021$42,311,000
+20.4%
510,873
-3.6%
0.01%
+18.2%
Q1 2021$35,155,000
-35.5%
530,158
-25.4%
0.01%
-38.9%
Q4 2020$54,505,000
+78.0%
710,348
-0.1%
0.02%
+50.0%
Q3 2020$30,621,000
-9.2%
711,126
-8.9%
0.01%
-14.3%
Q2 2020$33,732,000
+71.1%
781,001
+13.9%
0.01%
+40.0%
Q1 2020$19,719,000
-16.4%
685,397
+84.3%
0.01%
+11.1%
Q4 2019$23,589,000
+112.4%
371,901
-5.6%
0.01%
+125.0%
Q3 2019$11,104,000
+12.7%
394,022
+6.0%
0.00%0.0%
Q2 2019$9,854,000371,8620.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders